NR_293_ATI_PHARMACOLOGY_MIDTERM_SCRIPT_2026_COMPLETE_TESTED_ANSWERS.

NR 293 ATI PHARMACOLOGY MIDTERM
SCRIPT 2026 COMPLETE TESTED ANSWERS

◉ Naloxone. Answer: Opioid antagonist


◉ Naloxone - Clinical Use. Answer: Reverse opioid overdose


◉ Naloxone - Major Effects. Answer: Acute withdrawal, Pain return


◉ Albuterol. Answer: Beta-2 agonist → bronchodilation


◉ Albuterol - Adverse Effects. Answer: Tachycardia, Tremor, Anxiety


◉ Codeine. Answer: Prodrug → metabolized to morphine


◉ Codeine - Key Concept. Answer: Poor metabolizers = no pain
relief, Ultra-rapid metabolizers = toxicity


◉ NSAIDs. Answer: COX inhibition → ↓ prostaglandins


◉ NSAIDs - Major Adverse Effects. Answer: GI bleeding, Renal injury,
↑ BP

, ◉ SSRIs. Answer: Increase serotonin availability


◉ SSRIs - Adverse Effects. Answer: Sexual dysfunction, GI upset,
Serotonin syndrome (with interactions)


◉ Epinephrine. Answer: Alpha + beta agonist


◉ Epinephrine - Clinical Use. Answer: Anaphylaxis, cardiac arrest


◉ Atropine. Answer: Anticholinergic


◉ Atropine - Effects. Answer: Dry mouth, Urinary retention,
Confusion, Tachycardia


◉ Benzodiazepines. Answer: Enhance GABA → CNS depression


◉ Benzodiazepines - Uses. Answer: Anxiety, seizures, alcohol
withdrawal


◉ Amphetamines / Methylphenidate. Answer: Increase
dopamine/norepinephrine